Pharmafile Logo

long-term condition

- PMLiVE

Merck KGaA given FDA Fast Track designation for generalised myasthenia gravis drug

Cladribine capsules could become the first ever oral treatment for gMG

- PMLiVE

Major prostate cancer screening trial launched in UK

The £42m Transform trial will recruit men aged 50-74, with a lower age limit of 45 for some men

- PMLiVE

Pfizer’s PADCEV gets FDA approval for bladder cancer

Bladder cancer affects more than 614,000 people globally each year

- PMLiVE

AstraZeneca announces $2bn investment in US manufacturing

The new and expanded facilities will support production of rare disease drug treatments

- PMLiVE

PMEA 2025: a celebration of excellence in pharmaceutical marketing

This year’s Awards, held at the Sheraton Grand in London, included 20 categories

- PMLiVE

Merck agrees deal with Cidara Therapeutics worth almost $9.2bn

Cidara’s long-acting viral flu drug showed significant protection in phase 2 results

- PMLiVE

Novartis reports primary endpoint reached in phase 3 malaria trial

The treatment demonstrated non-inferiority to current standard of care

- PMLiVE

The Future of MSL Training – How Digital Technologies Are Shaping Success

Discover how pharmaceutical companies are using asynchronous platforms and microlearning to eliminate geographical barriers, track performance, and achieve cost-effective, consistent training for global teams.

Impetus Digital

- PMLiVE

J&J receives positive NICE recommendation for multiple myeloma treatment

The treatment is approved for use within the NHS in England and Wales

- PMLiVE

VML Portugal appoints Managing Director

Mariana Marta dos Santos is appointed as managing director

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links